Status: current, Primitive. Date: 31-Aug 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2041601000168115 | Gliclazide MR (Apotex) (trade product) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2041611000168117 | Gliclazide MR (Apotex) | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Gliclazide MR (Apotex) | Is a | trade product | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Gliclazide MR (Apotex) 30 mg modified release tablet | Is a | True | Gliclazide MR (Apotex) | Inferred relationship | Some | |
| Gliclazide MR (Apotex) 30 mg modified release tablet, 100 | has TP | True | Gliclazide MR (Apotex) | Inferred relationship | Some | |
| Gliclazide MR (Apotex) 30 mg modified release tablet, 100, blister pack | has TP | True | Gliclazide MR (Apotex) | Inferred relationship | Some |
Reference Sets
FHIR